J&J Going Generic? McNeil “Exploratory Project” May Pave The Way
This article was originally published in The Pink Sheet Daily
Executive Summary
“Patriot” division is appearing at trade shows in an “intelligence-gathering” capacity, McNeil says. An in-house generic operation would provide J&J with a greater share of profits than “authorized” generic deals.
You may also be interested in...
J&J’s Poon Joins Management Triumvirate With Vice Chairman Appointment
Worldwide Chairman-Medicines & Nutritionals Christine Poon joins the Office of the Chairman, which includes CEO Weldon and CFO Darretta. Poon retains management responsibility for the pharmaceutical business.
J&J’s Poon Joins Management Triumvirate With Vice Chairman Appointment
Worldwide Chairman-Medicines & Nutritionals Christine Poon joins the Office of the Chairman, which includes CEO Weldon and CFO Darretta. Poon retains management responsibility for the pharmaceutical business.
Andrx Expects Concerta "Authorized" Generic From J&J's Patriot Unit, Third Party
In a citizen petition, Andrx requests FDA re-evaluate its policy concerning the marketing of "authorized" generic versions of brand drugs. Petition urges the agency to seek formal input from FTC and Justice Department on potential anticompetitive effects.